These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Kyrle-like lesions in two patients with renal failure undergoing dialysis. Stone RA J Am Acad Dermatol; 1981 Dec; 5(6):707-9. PubMed ID: 7320271 [No Abstract] [Full Text] [Related]
7. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations]. Garini G; Savazzi G; Arisi L Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795 [No Abstract] [Full Text] [Related]
8. Baclofen neurotoxicity in uremic patients: is continuous ambulatory peritoneal dialysis less effective than intermittent hemodialysis? Chen YC; Chang CT; Fang JT; Huang CC Ren Fail; 2003 Mar; 25(2):297-305. PubMed ID: 12739836 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of uremic patients by automated peritoneal dialysis: study of 78 cases]. Karoui C; Ben Hamida F; Cherif M; Barbouch S; Kaaroud H; Ounissi M; Abderrahim E; Ben Abdallah T; Ben Moussa F; Ben Maiz H; Kheder A Tunis Med; 2007 Mar; 85(3):225-9. PubMed ID: 17668579 [TBL] [Abstract][Full Text] [Related]
11. Oxidative metabolism of peripheral blood neutrophils in chronic renal failure on conservative and dialysis treatment. Luciak M Arch Immunol Ther Exp (Warsz); 1992; 40(2):93-5. PubMed ID: 1299177 [No Abstract] [Full Text] [Related]
12. [Assessment of nutrition in dialysis patients and chronic uremic patients]. Liu H; Duan X; Li G Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942 [TBL] [Abstract][Full Text] [Related]
13. Kyrle's disease in patients with chronic renal failure. Hood AF; Hardegen GL; Zarate AR; Nigra TP; Gelfand MC Arch Dermatol; 1982 Feb; 118(2):85-8. PubMed ID: 7059223 [No Abstract] [Full Text] [Related]
14. Acquired perforating disease associated with chronic renal failure. Chang P; Fernández V Int J Dermatol; 1992 Feb; 31(2):117-8. PubMed ID: 1559735 [TBL] [Abstract][Full Text] [Related]
15. Current trends in dialysis therapy. Jacobs C Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692 [No Abstract] [Full Text] [Related]
16. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Aloni Y; Shany S; Chaimovitz C Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753 [TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of continuous ambulatory peritoneal dialysis. Friedman EA Annu Rev Med; 1984; 35():233-48. PubMed ID: 6372656 [TBL] [Abstract][Full Text] [Related]
18. Characterization of an animal model of continuous peritoneal dialysis in chronic renal impairment. Miller TE; Findon G; Rowe L Clin Nephrol; 1992 Jan; 37(1):42-7. PubMed ID: 1541064 [TBL] [Abstract][Full Text] [Related]
19. Calcific uremic arteriolopathy while on cinacalcet. Gonzalez-Parra E; Martin-Cleary C; Martin J; Ortiz A J Postgrad Med; 2011; 57(1):51-2. PubMed ID: 21206121 [No Abstract] [Full Text] [Related]
20. Phagocytic function in the uremic patient. Ringoir S; Vanholder R Contrib Nephrol; 1992; 100():15-24. PubMed ID: 1458900 [No Abstract] [Full Text] [Related] [Next] [New Search]